GlassScriptPhysician profile
Brett Z Schaeffer
NPI 1144753799
$2,625.47
in general payments reported to CMS, 2019-2025
11 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $473 · 2023: $624 · 2024: $1,271 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,096 · Food and Beverage: $863 · Education: $77.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,096.23 |
| Food and Beverage | $862.74 |
| Education | $77.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $1,193.28 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $317.64 | 2021-2025 | Ofev |
| Regeneron Healthcare Solutions, INC. | $226.63 | 2022-2023 | |
| Shionogi INC | $217.44 | 2022-2023 | Fetroja |
| Inari Medical, INC. | $150.40 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $149.81 | 2023-2024 | Airsupra, Breztri |
| Abbvie INC. | $123.97 | 2022 | |
| Glaxosmithkline, LLC. | $104.18 | 2023 | Nucala |
| Insmed, INC. | $77.83 | 2023-2025 | Arikayce, Brinsupri |
| Paratek Pharmaceuticals, INC. | $40.74 | 2022 | |
| Genzyme Corporation | $23.55 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Schaeffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.